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XDiscussion
Dr Craig Selzman (Chapel Hill, NC). That was a very nice pre-
sentation and a lot to take in in a short period of time. I am trying to
make some relevance out of this because it is almost like you make
the background for lung transplantation, but this is a hilar clamp
model. I waswondering if you could speculate on the role of temper-
ature andwhatwas the effect onmany of yourmarkers in thismodel.
Dr Yang. Thank you for your insightful comments. It is impor-
tant to maintain a lower temperature of the donor lung under clin-
ical situations. In this particular study our aim was to characterize
the inflammatory responses during lung IRI, and thus we purposely
maintained normal body temperature during occlusion and perfu-
sion. Thus we did not sort out the temperature factor in our model.
Dr Selzman. I guess what I was getting at is that normally the
temperature for a lung transplantation is a little bit lower.
Dr Yang. You are right.
Dr Selzman. Therefore I guess if you put a tape around a pulmo-
nary artery during a lobectomy and then you were going to reper-
fuse—therefore I would like you to try to speculate how you
might be able to figure that out. Also, did you administer any
kind of pulmonary protective agent before your experiment?
Dr Yang. It is feasible to lower the body temperature during re-
perfusion in our model, and it has been reported that hypothermia
ameliorates lung IRI. Although we did not address the temperature
factor in our model, I would speculate that a reduced temperature
would lower the inflammatory response during reperfusion. As
far as pretreatment is concerned, our laboratory has applied an
adenosine A2A receptor agonist, ATL313, to this model and found
that treatment before ischemia, as well as during reperfusion, is
quite protective.
Dr Selzman. Have you ever done this in your organ perfusion
model, your ex vivo model?
Dr Yang. You are talking about the isolated model previously?
Dr Selzman. It sounded like you had an isolated model.
Dr Yang. We do have an isolated, blood-perfused rabbit lung
model in our laboratory. In studies using this model, the isolated
lungs typically undergo cold ischemic storage followed by reperfu-
sion with blood at normal body temperature (37C) to simulate
a clinical lung transplantation. All groups were treated similarly
in terms of temperature. Therefore we could not determine from
these studies whether the temperature had been a factor of protec-
tion against IRI. However, even with lower ischemic temperature in
this model, reperfusion injury still existed, and intervention with
anti-inflammatory agents, such as ATL313, before reperfusion, is-
chemia, or both exerted significant protective effects. We did not
look into the effect of the temperature factor on lung IRI, but that
is an excellent point. It would be most interesting to design a study
to look into the role of lower temperature as part of the regimen to
prevent lung IRI after transplantation.rgery c March 2009
